Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

被引:0
|
作者
Zapilko, Veronika [1 ]
Moisio, Sanni [2 ]
Parikka, Mataleena [3 ]
Heinaniemi, Merja [2 ]
Lohi, Olli [1 ,4 ,5 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere 33100, Finland
[2] Univ Eastern Finland, Inst Biomed, Kuopio 70210, Finland
[3] Tampere Univ, Fac Med & Hlth Technol, Lab Infect Biol, Tampere 33100, Finland
[4] Tampere Univ Hosp, Dept Pediat, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
[5] Tampere Univ Hosp, Tays Canc Ctr, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
基金
芬兰科学院;
关键词
childhood pB-ALL; disease model; CRISPR/Cas9-based knock-in; zebrafish; CHROMOSOME TRANSLOCATIONS; EMBRYONIC-DEVELOPMENT; TEL GENE; TEL-AML1; FUSION; MECHANISMS; TRANSPOSON; EVOLUTION; REARRANGEMENTS; HEMATOPOIESIS;
D O I
10.3390/cancers15245821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Despite remarkable progress in the treatment of acute lymphoblastic leukemia (ALL) in recent years, it remains a significant contributor to pediatric cancer-related deaths. This highlights the urgent need for innovative therapeutic strategies that target the genetic alterations driving ALL. We built a novel zebrafish disease model for ETV6::RUNX1-positive ALL, which harbors secondary lesions in the two commonly mutated genes, pax5, and cdkn2a/b. The introduction of secondary mutations significantly augmented the incidence of disease. This model provides a valuable tool for investigating the etiological role of secondary mutations and facilitating the evaluation of drug sensitivities in the future.Abstract Approximately 25% of children with B-cell precursor acute lymphoblastic leukemia (pB-ALL) harbor the t(12;21)(p13;q22) translocation, leading to the ETV6::RUNX1 (E::R) fusion gene. This translocation occurs in utero, but the disease is much less common than the prevalence of the fusion in newborns, suggesting that secondary mutations are required for overt leukemia. The role of these secondary mutations remains unclear and may contribute to treatment resistance and disease recurrence. We developed a zebrafish model for E::R leukemia using CRISPR/Cas9 to introduce the human RUNX1 gene into zebrafish etv6 intron 5, resulting in E::R fusion gene expression controlled by the endogenous etv6 promoter. As seen by GFP fluorescence at a single-cell level, the model correctly expressed the fusion protein in the right places in zebrafish embryos. The E::R fusion expression induced an expansion of the progenitor cell pool and led to a low 2% frequency of leukemia. The introduction of targeted pax5 and cdkn2a/b gene mutations, mimicking secondary mutations, in the E::R line significantly increased the incidence in leukemia. Transcriptomics revealed that the E::R;pax5mut leukemias exclusively represented B-lineage disease. This novel E::R zebrafish model faithfully recapitulates human disease and offers a valuable tool for a more detailed analysis of disease biology in this subtype.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias
    Biloglav, Andrea
    Olsson-Arvidsson, Linda
    Theander, Johan
    Behrendtz, Mikael
    Castor, Anders
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2020, 59 (09) : 540 - 543
  • [32] Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia
    von Goessel, H.
    Jacobs, U.
    Semper, S.
    Krumbholz, M.
    Langer, T.
    Keller, T.
    Schrauder, A.
    van der Velden, V. H. J.
    van Dongen, J. J. M.
    Harbott, J.
    Panzer-Gruemayer, E. R.
    Schrappe, M.
    Rascher, W.
    Metzler, M.
    LEUKEMIA RESEARCH, 2009, 33 (08) : 1082 - 1088
  • [33] ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia
    Xu, Li S.
    Francis, Alyssa
    Turkistany, Shereen
    Shukla, Devanshi
    Wong, Alison
    Batista, Carolina R.
    DeKoter, Rodney P.
    EXPERIMENTAL HEMATOLOGY, 2019, 73 : 50 - 63
  • [34] Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases
    Rodriguez-Hernandez, Guillermo
    Hauer, Julia
    Martin-Lorenzo, Alberto
    Schaefer, Daniel
    Bartenhagen, Christoph
    Garcia-Ramirez, Idoia
    Auer, Franziska
    Gonzalez-Herrero, Ines
    Ruiz-Roca, Lucia
    Gombert, Michael
    Okpanyi, Vera
    Fischer, Ute
    Chen, Cai
    Dugas, Martin
    Bhatia, Sanil
    Linka, Rene Martin
    Garcia-Suquia, Marta
    Victoria Rascon-Trincado, Maria
    Garcia-Sanchez, Angel
    Blanco, Oscar
    Begona Garcia-Cenador, Maria
    Javier Garcia-Criado, Francisco
    Cobaleda, Cesar
    Alonso-Lopez, Diego
    De Las Rivas, Javier
    Muschen, Markus
    Vicente-Duenas, Carolina
    Sanchez-Garcia, Isidro
    Borkhardt, Arndt
    CANCER RESEARCH, 2017, 77 (16) : 4365 - 4377
  • [35] Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
    Barbany, Gisela
    Andersen, Mette K.
    Autio, Kirsti
    Borgstrom, Georg
    Franco, Lucia Cavalier
    Golovleva, Irina
    Heim, Sverre
    Heinonen, Kristina
    Hovland, Randi
    Johansson, Bertil
    Johannsson, Johann H.
    Kjeldsen, Eigil
    Nordgren, Ann
    Palmqvist, Lars
    Forestier, Erik
    LEUKEMIA RESEARCH, 2012, 36 (07) : 936 - 938
  • [36] MicroRNA-125b-1 and BLID Upregulation Resulting from a Novel IGH Translocation in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
    Tassano, Elisa
    Acquila, Maura
    Tavella, Elisa
    Micalizzi, Concetta
    Panarello, Claudio
    Morerio, Cristina
    GENES CHROMOSOMES & CANCER, 2010, 49 (08) : 682 - 687
  • [37] Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia
    Sudutan, Tugce
    Erbilgin, Yucel
    Hatirnaz Ng, Ozden
    Karaman, Serap
    Karakas, Zeynep
    Kucukcankurt, Fulya
    Celkan, Tiraje
    Timur, Cetin
    Ozdemir, Gul Nihal
    Hacisalihoglu, Sadan
    Gelen, Sema Aylan
    Sayitoglu, Muge
    LEUKEMIA & LYMPHOMA, 2022, 63 (12) : 2931 - 2939
  • [38] High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia
    Hoffmann, Jana
    Krumbholz, Manuela
    Gutierrez, Helia Pimentel
    Fillies, Marion
    Szymansky, Annabell
    Bleckmann, Kirsten
    zur Stadt, Udo
    Koehler, Rolf
    Kuiper, Roland P.
    Horstmann, Martin
    von Stackelberg, Arend
    Eckert, Cornelia
    Metzler, Markus
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [39] Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
    Gauert, Anton
    Olk, Nadine
    Pimentel-Gutierrez, Helia
    Astrahantseff, Kathy
    Jensen, Lasse D.
    Cao, Yihai
    Eggert, Angelika
    Eckert, Cornelia
    Hagemann, Anja I. H.
    CANCERS, 2020, 12 (07) : 1 - 13
  • [40] Coexistence of iAMP21 and ETV6-RUNX1 fusion in an adolescent with B cell acute lymphoblastic leukemia: literature review of six additional cases
    Jun Gu
    Alexandra Reynolds
    Lianghua Fang
    Corrie DeGraffenreid
    Kenneth Sterns
    Keyur P. Patel
    L. Jeffrey Medeiros
    Pei Lin
    Xinyan Lu
    Molecular Cytogenetics, 9